We generated BMDMs from C5aR−/− and WT mice, treated with or without PMX-53, a C5aR antagonist,31 following their implantation into WT or C5aR−/− tumor-bearing mice (Figures 2F, S3E, and S3F). Here, C5AR1 is linked to neoplasm.